KT Tape, a company that deals with drug-free pain relief, has launched its KT Recovery+ Wave, it was reported on Monday.
The company says that the product is a clinically proven and FDA approved wearable device that offers drug-free pain relief for sports injuries, knee pain, arthritis, back pain, carpal tunnel, sprains and more.
The new KT Recovery+ Wave utilises sensation-free electromagnetic pulses called pulsed shortwave therapy to decrease nerve hypersensitivity and relieve pain. It has a guaranteed battery life of 250 hours and is available at an MSRP of USD34.99.
AstraZeneca invests USD2bn in Summit Therapeutics to advance ADC and cancer-drug combinations
BRC Therapeutics participates in regulators' workshop advancing botanical drug development
Lupin announces receipt of US FDA tentative approval for Apixaban Oral Suspension
QIAGEN completes US QIAstat-Dx bloodstream infection portfolio with FDA clearance
Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC
FDA approves WELIREG and LENVIMA combination for previously treated advanced renal cell carcinoma
AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer
XtalPi submits US FDA IND application for KQTD-126 in chronic intestinal pain
Revvity launches IVDR-certified solution for early detection of type 1 diabetes
FDA Advisory Committee votes in favour of GRAIL's Galleri multi-cancer early detection test